Abstract:Senecavirus A (SVA) is an RNA virus in the family Picornaviridae that has been detected in swine-production systems and is associated with vesicular disease and neonate mortality. The viral capsid is composed of four structural proteins: VP1-VP4. Although the VP1 protein has been reported to be the most immunogenic protein in vivo, no information on the immunodominant regions of the SVA polyprotein is available. The objective of this study was to identify the immunodominant regions of SVA polyprotein using an enzyme-linked immunosorbent assay (ELISA) epitope-mapping approach. The binding effect of SVA polyclonal antibody (SVA-pAb), SVA-VP1 monoclonal antibodies (SVA-mAb), and SVA-positive sera from clinically affected animals were characterized using a set of 18 overlapping SVA VP1-derived peptides by indirect and blocking ELISAs. All VP1 peptides yielded significant signal against SVA-pAb and SVA-VP1-mAb upon indirect ELISA. One peptide (aa 1-20) showed significantly high optical density on SVA recombinant VP1 protein (rVP1) and whole-virus-based indirect ELISAs. The blocking ELISA results demonstrated that peptides spanning aa 165-185 and 225-245 had a 50 % or greater inhibitory effect on SVA-pAb, while six groups of overlapping peptides spanning aa 1-35, 45-80, 90-140, 150-170, 195-230, and 240-264 and two groups of overlapping peptides spanning aa 1-50 and 60-264 showed a 50 % inhibitory effect or greater on swine VP1-mAb and SVA-seropositive swine serum, respectively, against SVA rVP1. Three-dimensional protein homology modeling showed that the peptides binding SVA-pAb are located on the outer surface of the viral capsid, while SVA mAbs and swine-positive sere can bind to epitopes located in both the inner and outer surfaces of the capsid. These linear epitopes showed differential binding and inhibitory activity on mAb and pAb; however, further studies will be necessary to evaluate whether they can act as decoy or neutralizing epitopes. Because mAb antibodies demonstrated a high binding affinity for this set of peptides, this information could lay the foundation for generating and screening specific antibodies for therapeutic potential.

Cloning of SVDV structural protein gene and predictions of secondary structure and lymphocyte epitopes of structural protein

Analysis for characteristics of Coxsaekievirus A16 VP1 gene and prediction of B lymphocyte antigen epitopes in Zhejiang province, China

Construction of Cell Line Stably Expressing IBDV VP2 Protein Mutants

Preparation of monoclonal antibody and identification of two novel B cell epitopes to VP1 protein of porcine sapelovirus

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

Identification of a linear B-cell epitope on the "puff" loop of the Senecavirus A VP2 protein involved in receptor binding

Epitope Prediction of Vibrio Vulnificus Cytolysin and Construction of Phage Display Peptides

Identification of a Dominant Linear Epitope on the VP2 Capsid Protein of Porcine Parvovirus and Characterization of Two Monoclonal Antibodies with Neutralizing Abilities.

Identification of Antigenic Epitopes of Monoclonal Antibodies Against the VP2 Protein of the 25 Serotype of Bluetongue Virus.

Characterization of the immunodominant regions of Senecavirus A-VP1 structural protein via ELISA epitope mapping

The epitope of the VP1 protein of porcine parvovirus

Screening and identification of linear B-cell epitopes on structural proteins of African Swine Fever Virus

Candidate Peptide-Vaccine Induced Potent Protection Against Csfv and Identified A Principal Sequential Neutralizing Determinant on E2

Predicting the spatial structure of membrane protein and B-cell epitopes of the MPXV_VEROE6 strain of monkeypox virus

Epitopes screening and vaccine molecular design of PEDV S protein based on immunoinformatics

Optimal Expression and Purification of Sapelovirus A Structural Protein VP1, and Its Immunogenicity in Mice.

Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.

Immunogenicity analysis based on VP1 and VP2 proteins of bovine enterovirus

Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics

Design of multi-epitope vaccine against porcine rotavirus using computational biology and molecular dynamics simulation approaches